vs

Side-by-side financial comparison of INDEPENDENT BANK CORP (IBCP) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

INDEPENDENT BANK CORP is the larger business by last-quarter revenue ($58.9M vs $32.2M, roughly 1.8× OptimizeRx Corp). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs 15.6%, a 13.1% gap on every dollar of revenue. Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs 2.1%).

Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

IBCP vs OPRX — Head-to-Head

Bigger by revenue
IBCP
IBCP
1.8× larger
IBCP
$58.9M
$32.2M
OPRX
Higher net margin
IBCP
IBCP
13.1% more per $
IBCP
28.6%
15.6%
OPRX
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
2.1%
IBCP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBCP
IBCP
OPRX
OPRX
Revenue
$58.9M
$32.2M
Net Profit
$16.9M
$5.0M
Gross Margin
74.8%
Operating Margin
26.6%
Net Margin
28.6%
15.6%
Revenue YoY
-0.2%
Net Profit YoY
8.2%
6535.9%
EPS (diluted)
$0.81
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBCP
IBCP
OPRX
OPRX
Q1 26
$58.9M
Q4 25
$58.3M
$32.2M
Q3 25
$57.3M
$26.1M
Q2 25
$55.9M
$29.2M
Q1 25
$54.1M
$21.9M
Q4 24
$62.0M
$32.3M
Q3 24
$51.4M
$21.3M
Q2 24
$56.5M
$18.8M
Net Profit
IBCP
IBCP
OPRX
OPRX
Q1 26
$16.9M
Q4 25
$18.6M
$5.0M
Q3 25
$17.5M
$779.0K
Q2 25
$16.9M
$1.5M
Q1 25
$15.6M
$-2.2M
Q4 24
$18.5M
$-78.0K
Q3 24
$13.8M
$-9.1M
Q2 24
$18.5M
$-4.0M
Gross Margin
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Operating Margin
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
34.8%
26.6%
Q3 25
37.0%
7.9%
Q2 25
37.0%
10.9%
Q1 25
35.3%
-9.6%
Q4 24
36.7%
11.2%
Q3 24
33.7%
-40.2%
Q2 24
41.0%
-19.9%
Net Margin
IBCP
IBCP
OPRX
OPRX
Q1 26
28.6%
Q4 25
31.8%
15.6%
Q3 25
30.5%
3.0%
Q2 25
30.2%
5.2%
Q1 25
28.8%
-10.0%
Q4 24
29.8%
-0.2%
Q3 24
26.9%
-42.8%
Q2 24
32.8%
-21.3%
EPS (diluted)
IBCP
IBCP
OPRX
OPRX
Q1 26
$0.81
Q4 25
$0.88
$0.27
Q3 25
$0.84
$0.04
Q2 25
$0.81
$0.08
Q1 25
$0.74
$-0.12
Q4 24
$0.87
$0.00
Q3 24
$0.65
$-0.50
Q2 24
$0.88
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBCP
IBCP
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$174.9M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$510.6M
$128.3M
Total Assets
$5.6B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBCP
IBCP
OPRX
OPRX
Q1 26
$174.9M
Q4 25
$138.4M
$23.4M
Q3 25
$208.7M
$19.5M
Q2 25
$146.2M
$16.6M
Q1 25
$128.1M
$16.6M
Q4 24
$119.9M
$13.4M
Q3 24
$121.6M
$16.1M
Q2 24
$214.3M
Total Debt
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Stockholders' Equity
IBCP
IBCP
OPRX
OPRX
Q1 26
$510.6M
Q4 25
$503.0M
$128.3M
Q3 25
$490.7M
$122.3M
Q2 25
$469.3M
$119.3M
Q1 25
$467.3M
$116.3M
Q4 24
$454.7M
$117.0M
Q3 24
$452.4M
$114.5M
Q2 24
$430.5M
$121.0M
Total Assets
IBCP
IBCP
OPRX
OPRX
Q1 26
$5.6B
Q4 25
$5.5B
$176.9M
Q3 25
$5.5B
$170.3M
Q2 25
$5.4B
$169.3M
Q1 25
$5.3B
$167.8M
Q4 24
$5.3B
$171.2M
Q3 24
$5.3B
$165.2M
Q2 24
$5.3B
$172.9M
Debt / Equity
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBCP
IBCP
OPRX
OPRX
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
$76.7M
$7.1M
Q3 25
$18.2M
$3.2M
Q2 25
$19.0M
$4.6M
Q1 25
$31.7M
$3.9M
Q4 24
$63.2M
$198.0K
Q3 24
$17.2M
$1.8M
Q2 24
$8.7M
$782.0K
Free Cash Flow
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
$70.2M
$7.1M
Q3 25
$16.5M
$3.2M
Q2 25
$16.7M
$4.6M
Q1 25
$30.6M
$3.8M
Q4 24
$55.2M
$181.0K
Q3 24
$15.7M
$1.8M
Q2 24
$7.0M
$737.0K
FCF Margin
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
120.3%
22.0%
Q3 25
28.9%
12.2%
Q2 25
29.8%
15.6%
Q1 25
56.5%
17.5%
Q4 24
89.1%
0.6%
Q3 24
30.6%
8.3%
Q2 24
12.3%
3.9%
Capex Intensity
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
11.1%
0.0%
Q3 25
2.9%
0.0%
Q2 25
4.1%
0.0%
Q1 25
2.1%
0.1%
Q4 24
12.8%
0.1%
Q3 24
2.9%
0.1%
Q2 24
3.1%
0.2%
Cash Conversion
IBCP
IBCP
OPRX
OPRX
Q1 26
Q4 25
4.13×
1.41×
Q3 25
1.04×
4.11×
Q2 25
1.12×
2.98×
Q1 25
2.03×
Q4 24
3.42×
Q3 24
1.25×
Q2 24
0.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBCP
IBCP

Net Interest Income$46.9M80%
Noninterest Income$12.0M20%

OPRX
OPRX

Segment breakdown not available.

Related Comparisons